Search research articles
Contact Us
Filters
Showing results (121-130 of 244) with videos related to
Page
of 25
Sort By:
Cancer Immunology, Immunotherapy : CII
|
April 11, 2023
CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells
Anetta Marcinek, Bettina Brauchle, Lisa Rohrbacher, et al.
Nature Medicine
|
July 8, 2024
A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy
David M Cordas Dos Santos, Tobias Tix, Roni Shouval, et al.
Hematological Oncology
|
June 29, 2023
Cellular therapy in lymphoma
Anna Sureda, Pieternella J Lugtenburg, Marie José Kersten, et al.
Transplantation
|
October 25, 2006
Association of human leukocyte antigen haplotypes with posttransplant lymphoproliferative disease after solid organ transplantation
Marion Subklewe, René Marquis, Sylvain Choquet, et al.
Haematologica
|
May 13, 2014
Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse
Max Hubmann, Thomas Köhnke, Eva Hoster, et al.
Cancer Immunology, Immunotherapy : CII
|
May 8, 2023
Correction to: CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells
Anetta Marcinek, Bettina Brauchle, Lisa Rohrbacher, et al.
Blood Advances
|
July 6, 2022
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
Kai Rejeski, Andreas Burchert, Gloria Iacoboni, et al.
Cancer Immunology, Immunotherapy : CII
|
March 31, 2020
A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas
Martin F Orth, Veit Leonhard Buecklein, Eric Kampmann, et al.
Annals of Hematology
|
February 25, 2012
Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients
Annika Dufour, Friederike Schneider, Eva Hoster, et al.
Plos One
|
March 21, 2015
An advanced preclinical mouse model for acute myeloid leukemia using patients' cells of various genetic subgroups and in vivo bioluminescence imaging
Binje Vick, Maja Rothenberg, Nadine Sandhöfer, et al.
Page
of 25
Search research articles
Search
Showing results (121-130 of 244) with videos related to
Sort By:
Page
of 25
Cancer Immunology, Immunotherapy : CII
|
April 11, 2023
CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells
Anetta Marcinek, Bettina Brauchle, Lisa Rohrbacher, et al.
Nature Medicine
|
July 8, 2024
A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy
David M Cordas Dos Santos, Tobias Tix, Roni Shouval, et al.
Hematological Oncology
|
June 29, 2023
Cellular therapy in lymphoma
Anna Sureda, Pieternella J Lugtenburg, Marie José Kersten, et al.
Transplantation
|
October 25, 2006
Association of human leukocyte antigen haplotypes with posttransplant lymphoproliferative disease after solid organ transplantation
Marion Subklewe, René Marquis, Sylvain Choquet, et al.
Haematologica
|
May 13, 2014
Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse
Max Hubmann, Thomas Köhnke, Eva Hoster, et al.
Cancer Immunology, Immunotherapy : CII
|
May 8, 2023
Correction to: CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells
Anetta Marcinek, Bettina Brauchle, Lisa Rohrbacher, et al.
Blood Advances
|
July 6, 2022
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
Kai Rejeski, Andreas Burchert, Gloria Iacoboni, et al.
Cancer Immunology, Immunotherapy : CII
|
March 31, 2020
A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas
Martin F Orth, Veit Leonhard Buecklein, Eric Kampmann, et al.
Annals of Hematology
|
February 25, 2012
Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients
Annika Dufour, Friederike Schneider, Eva Hoster, et al.
Plos One
|
March 21, 2015
An advanced preclinical mouse model for acute myeloid leukemia using patients' cells of various genetic subgroups and in vivo bioluminescence imaging
Binje Vick, Maja Rothenberg, Nadine Sandhöfer, et al.
Page
of 25